ISRAPAFANT
UNII O3MCV749SW

Substance Identification & Data

This profile provides standardized clinical and technical data for Israpafant, uniquely identified by the FDA Unique Ingredient Identifier (UNII) O3MCV749SW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 117279-73-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

O3MCV749SW

CAS Registry Number

117279-73-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ISRAPAFANT

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C28H29ClN4S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

RMSWMRJVUJSDGN-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C65987

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

119175

Unique identification number in the NCBI database of chemical substances.

INN ID

7537

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(nnc2C(N=C(c3c(sc(c3)CCc4ccc(cc4)CC(C)C)-n12)c5c(cccc5)Cl)C)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Israpafant. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.